[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AR060182A1 - Polisacaridos capsulares tipo 5 y tipo 8 de cepas s. aureus de sobreproduccion - Google Patents

Polisacaridos capsulares tipo 5 y tipo 8 de cepas s. aureus de sobreproduccion

Info

Publication number
AR060182A1
AR060182A1 ARP070101300A ARP070101300A AR060182A1 AR 060182 A1 AR060182 A1 AR 060182A1 AR P070101300 A ARP070101300 A AR P070101300A AR P070101300 A ARP070101300 A AR P070101300A AR 060182 A1 AR060182 A1 AR 060182A1
Authority
AR
Argentina
Prior art keywords
type
capsular
aureus
polisacarids
cepas
Prior art date
Application number
ARP070101300A
Other languages
English (en)
Original Assignee
Sanofi Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur filed Critical Sanofi Pasteur
Publication of AR060182A1 publication Critical patent/AR060182A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Polisacáridos capsulares tipo 5 y tipo 8 producidos mediante cepas de S. aureus sobreproductoras, también se refiere a las composiciones inmunogenas y a las vacunas que comprenden dichos polisacáridos capsulares.
ARP070101300A 2006-03-31 2007-03-28 Polisacaridos capsulares tipo 5 y tipo 8 de cepas s. aureus de sobreproduccion AR060182A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0602795A FR2899110A1 (fr) 2006-03-31 2006-03-31 Polysaccharides capsulaires de type 5 et de type 8 des souches surproductrices de staphylococcus aureus

Publications (1)

Publication Number Publication Date
AR060182A1 true AR060182A1 (es) 2008-05-28

Family

ID=37460337

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070101300A AR060182A1 (es) 2006-03-31 2007-03-28 Polisacaridos capsulares tipo 5 y tipo 8 de cepas s. aureus de sobreproduccion

Country Status (7)

Country Link
US (1) US8338137B2 (es)
EP (2) EP2653164A1 (es)
JP (1) JP5237259B2 (es)
AR (1) AR060182A1 (es)
CA (1) CA2645365C (es)
FR (1) FR2899110A1 (es)
WO (1) WO2007118979A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7521221B2 (en) 2005-11-21 2009-04-21 Board Of Trustees Of The University Of Arknasas Staphylococcus aureus strain CYL1892
FR2899110A1 (fr) * 2006-03-31 2007-10-05 Sanofi Pasteur Sa Polysaccharides capsulaires de type 5 et de type 8 des souches surproductrices de staphylococcus aureus
CN102625713A (zh) * 2009-06-22 2012-08-01 惠氏有限责任公司 用于制备金黄色葡萄球菌血清型5和8荚膜多糖缀合物免疫原性组合物的组合物和方法
EP2493510B1 (en) 2009-09-30 2020-07-08 GlaxoSmithKline Biologicals SA Conjugation of staphylococcus aureus type 5 and type 8 capsular polysaccharides
US9060965B2 (en) * 2009-10-30 2015-06-23 Glaxosmithkline Biologicals Sa Purification of Staphylococcus aureus type 5 capsular saccharides
CN114480387B (zh) * 2022-01-05 2023-08-25 四川大学华西医院 一种金黄色葡萄球菌组成型启动子、表达载体及其构建方法、重组菌株及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2682388B1 (fr) 1991-10-10 1995-06-09 Pasteur Merieux Serums Vacc Procede de preparation d'un oligoside par depolymerisation d'un polyoside issu d'un agent pathogene, oligoside ainsi obtenu et son utilisation notamment comme agent vaccinal.
CA2246760C (en) * 1997-01-21 2012-01-10 Pasteur Merieux Serums & Vaccins Polysaccharide-peptide-conjugates
US20030113350A1 (en) * 2001-09-19 2003-06-19 Fattom Ali I. Glycoconjugate vaccines for use in immune-compromised populations
AU2003290867A1 (en) * 2002-11-12 2004-06-03 The Brigham And Women's Hospital, Inc. Methods and products for treating staphylococcal infections
CA2517439C (en) * 2003-03-07 2013-07-23 Wyeth Holdings Corporation Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
FR2884830A1 (fr) * 2005-04-25 2006-10-27 Sanofi Pasteur Sa Procede de production de souches de staphylococcus aureus surproductrices
US7521221B2 (en) * 2005-11-21 2009-04-21 Board Of Trustees Of The University Of Arknasas Staphylococcus aureus strain CYL1892
FR2899110A1 (fr) * 2006-03-31 2007-10-05 Sanofi Pasteur Sa Polysaccharides capsulaires de type 5 et de type 8 des souches surproductrices de staphylococcus aureus

Also Published As

Publication number Publication date
JP2009531398A (ja) 2009-09-03
EP2653164A1 (fr) 2013-10-23
US20110052624A1 (en) 2011-03-03
US8338137B2 (en) 2012-12-25
JP5237259B2 (ja) 2013-07-17
CA2645365A1 (en) 2007-10-25
CA2645365C (en) 2016-09-27
WO2007118979A1 (fr) 2007-10-25
EP2004223A1 (fr) 2008-12-24
FR2899110A1 (fr) 2007-10-05

Similar Documents

Publication Publication Date Title
CR20150097A (es) Composición inmunogénica
PE20142188A1 (es) Composiciones inmunogenicas de antigenos de staphylococcus aureus
NZ597191A (en) Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
NZ596254A (en) Cleanser compositions and methods for using the same comprising linalool, hinokitiol, diol and surfactant
JO3257B1 (ar) مركبات وتركيبات كمعدلات لفاعلية tlr
ME01199B (me) Nove kompozicije adjuvanta
PE20142115A1 (es) Composiciones de neisseria meningitidis y metodos de las mismas
CL2012002195A1 (es) Composicion inmunogénica que comprende una mezcla de conjugados de polisacaridos-proteina multivalente que consiste en polisacáridos capsulares de streptococcus pneumoniae; metodo para inducir una respuesta inmune a un polisacarido capsular de streptococcus pneumoniae.
UY29373A1 (es) Derivados del 1,5-diarilpirrol, su preparación y su aplicación en terapeutica
EA201101530A1 (ru) ИММУНОНАНОТЕРАПИЯ, ОБЕСПЕЧИВАЮЩАЯ Th1-СМЕЩЕННЫЙ ОТВЕТ
CO6690760A2 (es) Variantes no lipidadas de antígenos orf2086 de neisseria meningitidis
CL2012000744A1 (es) Proceso para preparar un conjugado de polisacáridos capsulares tipo 5 o tipo 8 de s. aureus y una molécula transportadora; conjugado de polisacáridos; y composición inmunogénica que lo comprende.
AR044696A1 (es) Composicion de vacunas
AR060182A1 (es) Polisacaridos capsulares tipo 5 y tipo 8 de cepas s. aureus de sobreproduccion
HN2008001393A (es) Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
UY29416A1 (es) Derivados de ácido pirimidincarboxílico y su uso
HN2010001537A (es) Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
RS53907B1 (en) USE OF NIFURATEL FOR TREATMENT OF ATOPOBIUM-CAUSED INFECTIONS
CA2800424C (en) B1,2 cyclic beta glucan compound for use to enhance adaptive immunity by activation of dendritic cells
CR9565A (es) Derivados del 4,5-diarilpirrol, su preparacion y su aplicacion en terapeutica
GB2452892A (en) Process for culturing bacteria of the piscirickettsia genus
UA97359C2 (en) Immunogenic composition
MX2011006504A (es) Composicion de control de enfermedades vegetales, metodo de control de enfermedades vegetales, y nuevo microorganismo.
CO6541608A2 (es) Formulación de empaque para evitar la insolubilidad de las composiciones que contienen quitosán
CR10382A (es) 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzazepinas, su preparacion, composiciones que las contienen y utilizacion

Legal Events

Date Code Title Description
FB Suspension of granting procedure